Le Lézard
Classified in: Transportation, Science and technology, Business
Subject: LIC

LawGistic Partners Joins Lexitas


HOUSTON, May 8, 2024 /PRNewswire/ -- Lexitas, a leading provider of technology-enabled litigation services and a portfolio company of funds advised by Apax, announced that LawGistic Partners has joined Lexitas. LawGistic Partners has sixteen years of experience providing service of process, investigations, and courier services throughout the United States.

"I am enthusiastic to welcome LawGistic Partners to the Lexitas family. Their dedication to service excellence, decades of experience, and culture make them the perfect fit for our Process Service division." said Ross Mallor, Process Service Division President at Lexitas.

David Cofman, President and Founder of LawGistic Partners said, "For the past 16 years, Lawgistic Partners has been dedicated to becoming the best-in-class legal document support provider. Lexitas shares our unwavering commitment to our core values of innovation, quality, and professionalism. I am enthusiastic about the prospect of leveraging LawGistic Partners legacy within the framework of an exceptional and dedicated team of professionals with a likeminded commitment to excellence."

Founded in 1987, Lexitas is a leading national provider of legal support services to law firms, corporations, and insurance companies. Services include court reporting, record retrieval, process service, registered agent, legal staffing, document review and commercial contracts outsourcing. For more information visit https://lexitaslegal.com and https://www.lawgisticpartners.com/.

SOURCE Lexitas


These press releases may also interest you

at 17:20
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health awarded Panda Health Partner status for its Orchestral Health Intelligence Platform
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital's Technology Fund I Recognized as Top Performing VC Fund in the Preqin League Tables
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

More news about Science and technology...


News published on and distributed by: